Letermovir (LMV) Prophylaxis in CMV-seronegative Allogeneic Stem Cell Transplant Recipients With CMV Seropositive Donors: an Exploratory Study From Spanish GETH/TC Centers
Clinical trial NCT06211543 · UNKNOWN
Trial details
- NCT number
- NCT06211543
- Sponsor
- Grupo Espanol de trasplantes hematopoyeticos y terapia celular
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2024-03-30
- Primary completion
- 2025-09-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.